作者: Michael Flynn , Margaret Jamison , Santanu Datta , Evan Myers
DOI: 10.1016/J.AJOG.2006.02.020
关键词:
摘要: Objective The purpose of this study was to quantify the total direct cost US health care system for management uterine leiomyomas. Study design We used Center Disease Control heath databases estimates inpatient care, ambulatory and outpatient With International Classification Diseases–9 codes fibroid tumors fibroid-related conditions, all identified in each database. Inpatient surgical cases were stratified by procedure, clinical categorized type visit provider. use Medicare's RBRVU reimbursement rates 2000 as a proxy physician services Medicare diagnostic-related group facility costs, estimated. Results Total treat estimated at $2,151,484,847. Most due particular, hysterectomy. Conclusion Uterine consume significant amount resources United States.